Clinical Trial Update: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update for AR-67 in adults with recurrent glioblastoma multiforme or gliosarcoma. The current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin)

Snippet

Sponsor: Arno Therapeutics | Conditions: Glioblastoma Multiforme, GBM | Phase 2 | Status: UNKNOWN